← Back to Search

Orthopedic Implant

Total Hip Arthroplasty for Osteoarthritis (PIN DM Trial)

N/A

Waitlist Available

Led By Thomas Turgeon, MD

Research Sponsored by DePuy Orthopaedics

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks, 1 year, 2 years

Awards & highlights

PIN DM Trial Summary

This trial is testing a new hip implant to see how well it works compared to a similar device.

Eligible Conditions

Osteoarthritis
Joint Replacement

PIN DM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks, 1 year, 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks, 1 year, 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks, 1 year, 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Superior Cup Migration

Secondary outcome measures

Additional RSA Measurements

FJS-12

HOOS Jr Score

+3 more

Other outcome measures

Acetabular cup subsidence with a prior to discharge baseline

Correlation of functional and health status outcomes vs. RSA

Mean change from baseline values of Harris Hip Score, HOOS Jr. and Forgotten Joint Score

+1 more

PIN DM Trial Design

2Treatment groups

Experimental Treatment

Group I: Total Hip ArthroplastyExperimental Treatment1 Intervention

Pinnacle acetabular shells used with PINNACLE DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses

Group II: Revision Total Hip ArthroplastyExperimental Treatment1 Intervention

Pinnacle acetabular shells used with Pinnacle DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Total Hip Arthroplasty

2014

Completed Phase 4

~1360

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

DePuy OrthopaedicsLead Sponsor

79 Previous Clinical Trials

25,828 Total Patients Enrolled

44 Trials studying Osteoarthritis

10,902 Patients Enrolled for Osteoarthritis

Thomas Turgeon, MDPrincipal InvestigatorConcordia Joint Replacement Group, Concordia Hip and Knee Institute & University of Manitoba

8 Previous Clinical Trials

370 Total Patients Enrolled

1 Trials studying Osteoarthritis

30 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for enrollment in this research endeavor at the present time?

"According to information on clinicaltrials.gov, this medical research is actively seeking participants. The trial was initially posted on October 6th 2022 and recently updated November 28th 2022."

Answered by AI

How many individuals are being recruited to participate in this trial?

"This study necessitates the involvement of 45 eligible patients. DePuy Orthopaedics have appointed various sites to conduct the trial, which include Concordia Joint Replacement Group & Concordia Hip and Knee Institute in Winnipeg as well as QEII Health Sciences Centre & Dalhousie University in Halifax."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PINNACLE® DM RSA Study

2022. "PINNACLE® DM RSA Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05357664.